Filing Details
- Accession Number:
- 0001415889-25-016003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-06 16:47:48
- Reporting Period:
- 2025-06-05
- Filing Date:
- 2025-06-06
- Accepted Time:
- 2025-06-06 16:47:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1741830 | Kronos Bio Inc. | KRON | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1931509 | Deborah Knobelman | C/O Kronos Bio, Inc. 301 Binney Street, 2Nd Floor East Cambridge MA 02142 | President & Interim Ceo | No | No | No | No |
Transaction Summary
Sold: | 24,838 shares | Avg. Price: $0.87 | Total Value: $21,554.42 |
Number of Shares After Transactions: | 139,422 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-06-05 | 24,838 | $0.87 | 139,422 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.